Cancer
Recent research conducted by Li-Yun Duan and colleagues at Guang'anmen Hospital in Beijing, China, suggests that certain antidiabetic drugs may have a protective effect against cancer in patients with type 2 diabetes mellitus (T2DM). The study, published in the World Journal of Diabetes, involved a systematic review and
Cancer
Recent research conducted by Li-Yun Duan and colleagues at Guang'anmen Hospital in Beijing, China, suggests that certain antidiabetic drugs may have a protective effect against cancer in patients with type 2 diabetes mellitus (T2DM). The study, published in the World Journal of Diabetes, involved a systematic review and
Cancer patients
Researchers in Shijiazhuang, People's Republic of China, have conducted a study to evaluate the diagnostic consistency between the Global Leadership Initiative on Malnutrition (GLIM) criteria and the Patient-Generated Subjective Global Assessment (PG-SGA) for identifying malnutrition in patients with pancreatic malignant tumors. The study aimed to assess the effectiveness
Cancer research
Recent research conducted by Li-Yun Duan and colleagues at Guang'anmen Hospital in Beijing, China, suggests that certain antidiabetic drugs may have a protective effect against cancer in patients with type 2 diabetes mellitus (T2DM). The study, published in the World Journal of Diabetes, involved a systematic review and
Cancer patients
Researchers in Shijiazhuang, People's Republic of China, have conducted a study to evaluate the diagnostic consistency between the Global Leadership Initiative on Malnutrition (GLIM) criteria and the Patient-Generated Subjective Global Assessment (PG-SGA) for identifying malnutrition in patients with pancreatic malignant tumors. The study aimed to assess the effectiveness
Cancer research
Researchers in Shijiazhuang, People's Republic of China, have conducted a study to evaluate the diagnostic consistency between the Global Leadership Initiative on Malnutrition (GLIM) criteria and the Patient-Generated Subjective Global Assessment (PG-SGA) for identifying malnutrition in patients with pancreatic malignant tumors. The study aimed to assess the effectiveness
Cancer
Recent research conducted by Li-Yun Duan and colleagues at Guang'anmen Hospital in Beijing, China, suggests that certain antidiabetic drugs may have a protective effect against cancer in patients with type 2 diabetes mellitus (T2DM). The study, published in the World Journal of Diabetes, involved a systematic review and
Cancer patients
Researchers in Shijiazhuang, People's Republic of China, have conducted a study to evaluate the diagnostic consistency between the Global Leadership Initiative on Malnutrition (GLIM) criteria and the Patient-Generated Subjective Global Assessment (PG-SGA) for identifying malnutrition in patients with pancreatic malignant tumors. The study aimed to assess the effectiveness
Cancer patients
The COVID-19 pandemic has significantly impacted routine monitoring of patients with head and neck cancer (HNC) and oral potentially malignant disorders (OPMDs), leading to delayed diagnoses and worse outcomes. According to a recent study published in Medicina Oral Patologia Oral Y Cirugia Bucal, researchers from the State University of Campinas
Cancer
Recent research conducted by Li-Yun Duan and colleagues at Guang'anmen Hospital in Beijing, China, suggests that certain antidiabetic drugs may have a protective effect against cancer in patients with type 2 diabetes mellitus (T2DM). The study, published in the World Journal of Diabetes, involved a systematic review and
Cancer patients
The COVID-19 pandemic has significantly impacted routine monitoring of patients with head and neck cancer (HNC) and oral potentially malignant disorders (OPMDs), leading to delayed diagnoses and worse outcomes. According to a recent study published in Medicina Oral Patologia Oral Y Cirugia Bucal, researchers from the State University of Campinas
Cancer patients
Researchers at the University of Oxford have launched a trial in Bristol to explore the potential of artificial intelligence (AI) in making better treatment decisions for prostate cancer patients. The Vanguard Path study aims to address the challenge faced by doctors in determining the aggressiveness of the disease in individual
